US › Healthcare

Valion Bio Inc (VBIO)

US · Healthcare · Biotechnology

$1.17-4.88%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$1.1M

Revenue YoY

+1190.3%

Net profit

$-7.1M

EPS

$-2.17

Net margin

-640.1%

Key statistics

Market cap

$3.0M

Forward P/E

0.0

P/B

0.52

Book value

$25.57

EPS (TTM)

$-177.91

52-week high

$75.50

52-week low

$1.44

50-day MA

$3.59

200-day MA

$17.56

Beta

1.80

Shareholding

Insiders

0.63%

Institutions

12.42%

Largest institutional holders

Fund	Stake
Murchinson Ltd.	0.52%
Sanctuary Advisors, LLC	0.28%
Marex Group Ltd	0.24%
Virtu Financial LLC	0.18%
Geode Capital Management, LLC	0.09%
HRT FINANCIAL LLC	0.05%
UBS Group AG	0.05%
TWO SIGMA SECURITIES, LLC	0.05%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Valion Bio Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.